News:Research and scientific results

An international team of researchers, led at the BBRC, has discovered that a series of biomarkers recently described to detect the most advanced phase of Alzheimer's can also detect the preclinical phase of the disease in the cerebrospinal fluid and plasma.

The digitization of the data collected in our studies allows us to accelerate our research, improve its integrity and make it available to researchers around the world.

Discover #undíaparaolvidar

Dr José Luis Molinuevo comments the possible approval of Biogen’s new treatment, in an interview for the podcast Saving Minds.

The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor

The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy

BBRC participates with the PENSA study

BBRC researchers have detected that people most exposed to air pollution have greater brain atrophy and less cortical thickness in specific areas of the brain that are affected in Alzheimer's disease.

Four researchers explain in a video (in Spanish) how they are working with this new scenario